SEARCH

SEARCH BY CITATION

References

  • 1
    Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003; 14: 121146.
  • 2
    Olivry T, Foster AP, Mueller RS et al. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Veterinary Dermatology 2010; 21: 422.
  • 3
    Olivry T, DeBoer DJ, Favrot C et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010; 21: 233248.
  • 4
    Moriello KA. Treatment of dermatophytosis in dogs and cats: review of published studies. Veterinary Dermatology 2004; 15: 99107.
  • 5
    Nuttall T, Cole LK. Evidence-based veterinary dermatology: a systematic review of interventions for treatment of Pseudomonas otitis in dogs. Veterinary Dermatology 2007; 18: 6977.
  • 6
    Noli C, Auxilia ST. Treatment of canine Old World visceral leishmaniasis: a systematic review. Veterinary Dermatology 2005; 16: 213232.
  • 7
    Leung DY, Nicklas RA, Li JT et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Annals of Allergy, Asthma & Immunology 2004; 93: S1S21.
  • 8
    Mueller RS. Treatment protocols for demodicosis: an evidence-based review. Veterinary Dermatology 2004; 15: 7589.
  • 9
    Paterson TE, Halliwell RE, Fields PJ et al. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate® (Bayer Animal Health) with ivermectin. Veterinary Dermatology 2009; 20: 447455.
  • 10
    Schnabl B, Bettenay S, Glos N et al. Oral selamectin in the treatment of canine generalised demodicosis. Veterinary Record 2010; 166: 710714.
  • 11
    Henpf Olschewski C. Hat Jeder Hautgesunde Hund Demodexmilben? Histologische Untersuchungen von Hautproben. Berlin: Freie Universität, 1988; 141.
  • 12
    Greve JH, Gaafar SM. Natural transmission of Demodex canis in dogs. Journal of the American Veterinary Medical Association 1966; 148: 10431045.
  • 13
    Chesney CJ. Short form of Demodex species mite in the dog: occurrence and measurements. Journal of Small Animal Practice 1999; 40: 5861.
  • 14
    Desch CE, Hillier A. Demodex injai: a new species of hair follicle mite (Acari: Demodecidae) from the domestic dog (Canidae). Journal of Medical Entomology 2003; 40: 146149.
  • 15
    Hillier A, Desch CE. Large-bodied Demodex mite infestation in 4 dogs. Journal of the American Veterinary Medical Association 2002; 220: 623627, 613.
  • 16
    Mueller RS, Bettenay SV. An unusual presentation of generalised demodicosis caused by a long-bodied demodex mite in a Lakeland Terrier. Australian Veterinary Practitioner 1999; 29: 128131.
  • 17
    Ordeix L, Bardagi M, Scarampella F et al. Demodex injai infestation and dorsal greasy skin and hair in eight wirehaired fox terrier dogs. Veterinary Dermatology 2009; 20: 267272.
  • 18
    Robson DC, Burton GG, Bassett R et al. Eight cases of demodicosis caused by a long-bodied Demodex species (1997–2002). Australian Veterinary Practice 2003; 33: 6472.
  • 19
    Chen C. A short-tailed demodectic mite and Demodex canis infestation in a Chihuahua dog. Veterinary Dermatology 1995; 6: 227229.
  • 20
    Saridomichelakis M, Koutinas A, Papadogiannakis E et al. Adult-onset demodicosis in two dogs due to Demodex canis and a short-tailed demodectic mite. Journal of Small Animal Practice 1999; 40: 529532.
  • 21
    Bourdeau P. Variation in size in Demodex canis: from the longest to the shortest forms. Veterinary Dermatology 2010; 21: 213 (Abstract).
  • 22
    Plant JD, Lund EM, Yang M. A case–control study of the risk factors for canine juvenile-onset generalized demodicosis in the USA. Veterinary Dermatology 2011; 22: 9599.
  • 23
    Duclos DD, Jeffers JG, Shanley KJ. Prognosis for treatment of adult-onset demodicosis in dogs: 34 cases (1979–1990). Journal of the American Veterinary Medical Association 1994; 204: 616619.
  • 24
    Lemarie S, Hosgood G, Foil CS. A retrospective study of juvenile- and adult-onset generalized demodicosis in dogs (1986–1991). Veterinary Dermatology 1996; 7: 310.
  • 25
    Miller WH Jr, Scott DW, Wellington JR et al. Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs. Journal of the American Veterinary Medical Association 1993; 203: 14261429.
  • 26
    Garfield RA, Lloyd R. The use of oral milbemycin oxime (Interceptor) in the treatment of chronic generalized canine demodicosis. Veterinary Dermatology 1992; 3: 231235.
  • 27
    Scott DW, Miller WH Jr, Griffin CE. Canine demodicosis. Muller & Kirk’s Small Animal Dermatology. Philadelphia, W.B. Saunders, 2001: 457474.
  • 28
    Bruzinska-Schmidhalter R, Nett-Mettler CS. Spontaneous remission in canine generalized demodicosis – predisposing factors. Veterinary Dermatology 2011; 22: 301 (Abstract).
  • 29
    Fondati A. Efficacy of daily oral ivermectin in the treatment of 10 cases of generalized demodicosis. Veterinary Dermatology 1996; 7: 99104.
  • 30
    Mueller RS, Meyer D, Bensignor E et al. Treatment of canine generalized demodicosis with a ‘spot-on’ formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate®, Bayer Healthcare). Veterinary Dermatology 2009; 20: 441446.
  • 31
    Mueller RS, Bettenay SV. Skin scrapings and skin biopsies. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. Philadelphia, W.B. Saunders, 2010; 368371.
  • 32
    Beco L, Fontaine F, Bergvall K et al. Comparison of skin scrapes and hair plucks for detecting Demodex mites in canine demodicosis, a multicentre, prospective study. Veterinary Dermatology, 2007; 18: 381 (Abstract).
  • 33
    Bensignor E. Comparaison de trois techniques diagnostiques de demodecie a Demodex canis chez le chien. Pratique Medicale and Chirurgicale de l’Animal de Compagnie 2003; 38: 167171.
  • 34
    Fondati A, De LuciaM, Furiani N et al. Prevalence of Demodex canis-positive healthy dogs at trichoscopic examination. Veterinary Dermatology 2010; 21: 146151.
  • 35
    Kwochka KW, Kowalski JJ. Prophylactic efficacy of four antibacterial shampoos against Staphylococcus intermedius in dogs. American Journal of Veterinary Research 1991; 52: 115118.
  • 36
    Mueller RS. Topical dermatological therapy. In: Maddison JE, Page SW, Church DB, eds. Small Animal Pharmacology. Philadelphia, W.B. Saunders, 2008; 546556.
  • 37
    Hugnet C, Bruchon-Hugnet C, Royer H et al. Efficacy of 1.25% amitraz solution in the treatment of generalized demodicosis (eight cases) and sarcoptic mange (five cases) in dogs. Veterinary Dermatology 2001; 12: 8992.
  • 38
    Kwochka KW, Kunkle GA, Foil CS. The efficacy of amitraz for generalized demodicosis in dogs: a study of two concentrations and frequencies of application. The Compendium on Continuing Education for the Practising Veterinarian 1985; 7: 817.
  • 39
    Medleau L, Willemse T. Efficacy of daily amitraz therapy for refractory, generalized demodicosis in dogs: two independent studies. Journal of the American Animal Hospital Association 1995; 31: 246249.
  • 40
    Muller GH. Amitraz treatment of demodicosis. Journal of the American Animal Hospital Association 1983; 19: 435441.
  • 41
    Mueller RS, Bettenay SV. Milbemycin oxime in the treatment of canine demodicosis. Australian Veterinary Practitioner 1995; 25: 122126.
  • 42
    Fourie LJ, Kok DJ, du Plessis A et al. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of demodectic mange in dogs. Veterinary Parasitology 2007; 150: 268274.
  • 43
    Rosenkrantz W. Efficacy of metaflumizone plus amitraz for the treatment of juvenile and adult onset demodicosis in dogs: pilot study of 24 dogs. Veterinary Dermatology 2009; 20: 227 (Abstract).
  • 44
    Oberkirchner U, Linder K, Dunston S et al. Metaflumizone–amitraz (Promeris)-associated pustular acantholytic dermatitis in 22 dogs: evidence suggests contact drug-triggered pemphigus foliaceus. Veterinary Dermatology 2011; 22: 436448.
  • 45
    Holm BR. Efficacy of milbemycin oxime in the treatment of canine generalized demodicosis: a retrospective study of 99 dogs (1995–2000). Veterinary Dermatology 2003; 14: 189195.
  • 46
    Sasaki Y, Kitagawa H, Murase S. Susceptibility of rough-coated collies to milbemycin oxime. Japanese Journal of Veterinary Science 1990; 52: 12691271.
  • 47
    Barbet JL, Snook T, Gay JM et al. ABCB1-1Δ (MDR1-1Δ) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis. Veterinary Dermatology 2009; 20: 111114.
  • 48
    Scott DW, Walton DK. Experiences with the use of amitraz and ivermectin for the treatment of generalized demodicosis in dogs. Journal of the American Animal Hospital Association 1985; 21: 535541.
  • 49
    Ristic Z, Medleau L, Paradis M et al. Ivermectin for treatment of generalized demodicosis in dogs. Journal of the American Veterinary Medical Association 1995; 207: 13081310.
  • 50
    Guaguere E. Traitement de la demodecie generalisee du chien par l’ivermectine: a propos de 20 cas. Pratique Medicale et Chirurgicale de l’Animal de Compagnie 1996; 31: 3140.
  • 51
    Medleau L, Ristic Z, McElveen DR. Daily ivermectin for the treatment of generalized demodicosis in dogs. Veterinary Dermatology 1996; 7: 209212.
  • 52
    Mueller RS, Hastie K, Bettenay SV. Daily oral ivermectin for the treatment of generalised demodicosis in 23 dogs. Australian Veterinary Practitioner 1999; 29: 132136.
  • 53
    Delayte EH, Otsuka M, Larsson CE et al. Efficacy of systemic macrocyclic lactones (ivermectin and moxidectin) for the treatment of generalized canine demodicosis. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2006; 58: 3138.
  • 54
    Mueller RS, Bettenay SV. A proposed new therapeutic protocol for the treatment of canine mange with ivermectin. Journal of the American Animal Hospital Association 1999; 35: 7780.
  • 55
    Hugnet C, Lespine A, Alvinerie M. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. Journal of Pharmacy and Pharmaceutical Sciences 2007; 10: 311318.
  • 56
    Mayer UK, Glos K, Schmid M et al. Adverse effects of ketoconazole in dogs – a retrospective study. Veterinary Dermatology 2008; 19: 199208.
  • 57
    Mealey KL, Bentjen SA, Gay JM et al. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001; 11: 727733.
  • 58
    Mealey KL, Meurs KM. Breed distribution of the ABCB1-1Δ (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping. Journal of the American Veterinary Medical Association 2008; 233: 921924.
  • 59
    Roulet A, Puel O, Gesta S et al. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. European Journal of Pharmacology 2003; 460: 8591.
  • 60
    Bissonnette S, Paradis M, Daneau I et al. The ABCB1-1Δ mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis. Veterinary Dermatology 2009; 20: 6066.
  • 61
    Bensignor E, Carlotti D. Moxidectin in the treatment of generalized demodicosis in dogs. A pilot study: 8 cases. In: Kwochka KW, Willemse T, Von Tscharner C, eds. Advances in Veterinary Dermatology. Oxford, Butterworth-Heinemann, 1998; 554555.
  • 62
    Burrows A. Evaluation of the clinical efficacy of two different doses of moxidectin in the treatment of generalized demodicosis in the dog. Annual Meeting of the Australian College of Veterinary Scientists, Goold Coast, Australia, 1997.
  • 63
    Wagner R, Wendlberger U. Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites. Veterinary Parasitology 2000; 93: 149158.
  • 64
    Heine J, Krieger K, Dumont P et al. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitological Research 2005; 97(Suppl 1): S89S96.
  • 65
    Fourie JJ, Delport PC, Fourie LJ et al. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate®) against generalised demodicosis in dogs. Parasitological Research 2009; 105(Suppl 1): S115S124.
  • 66
    Johnstone IP. Doramectin as a treatment for canine and feline demodicosis. Australian Veterinary Practitioner 2002; 32: 98103.
  • 67
    Murayama N, Shibata K, Nagata M. Efficacy of weekly oral doramectin treatment in canine demodicosis. Veterinary Record 2010; 167: 6364.
  • 68
    Schnieder T, Kordes S, Epe C et al. Investigations into the prevention of neonatal Toxocara canis infections in puppies by application of doramectin to the bitch. Zentralblatt für Veterinärmedizin. Reihe B 1996; 43: 3543.
  • 69
    Schnieder T, Lechler M, Epe C et al. The efficacy of doramectin on arrested larvae of Ancylostoma caninum in early pregnancy of bitches. Zentralblatt für Veterinärmedizin. Reihe B 1996; 43: 351356.
  • 70
    Lavy E, Aroch I, Bark H et al. Evaluation of doramectin for the treatment of experimental canine spirocercosis. Veterinary Parasitology 2002; 109: 6573.
  • 71
    Yas-Natan E, Shamir M, Kleinbart S et al. Doramectin toxicity in a collie. Veterinary Record 2003; 153: 718720.
  • 72
    Geyer J, Klintzsch S, Meerkamp K et al. Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis. Journal of Veterinary Pharmacology and Therapeutics 2007; 30: 482485.
  • 73
    Miller WH Jr, Wellington JR Scott DW. Dermatologic disorders of Chinese Shar Peis: 58 cases (1981–1989). Journal of the American Veterinary Medical Association 1992; 200: 986990.
  • 74
    Hamann F, Wedell H, Bauer J. Zur Demodikose des Hundes. Kleintierpraxis 1997; 42: 745754.
  • 75
    Folz SD, Kratzer DD, Conklin RD et al. Chemotherapeutic treatment of naturally acquired generalized demodicosis. Veterinary Parasitology 1983; 13: 8593.
  • 76
    Anon. Dermatologists recommend neutering of canine patients with demodicosis. Journal of the American Veterinary Medical Association 1983; 182: 1048.